CEL-SCI Corporation (NYSEAMEX:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology. CEL-SCI Corporation witnessed volume of 10.27 million shares during last trade however it holds an average trading capacity of 1.59 million shares.

CEL-SCI Corporation (NYSEAMEX:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology. CEL-SCI Corporation witnessed volume of 9.03 million shares during last trade however it holds an average trading capacity of 884,499 shares.

CEL-SCI Corporation (NYSEAMEX:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology. CEL-SCI Corporation witnessed volume of 2.07 million shares during last trade however it holds an average trading capacity of 821,459 shares.

CEL-SCI Corporation (AMEX:CVM) witnessed volume of 2.67 million shares during last trade however it holds an average trading capacity of 714,095.00 shares. CVM last trade opened at $0.34 reached intraday low of $0.31 and went +19.35% up to close at $0.37.

Read Full Article and Disclaimer at:http://stockbling.com/7752/stock-highlights/irregular-volume-of-cel-sci-...